​

Weight loss medications is a topic in the health domain with significant developments in policy, regulation, and public health impact.

Key developments include glp-1 drugs linked to reduced asthma and copd attacks in new studies, uk becomes first european country to approve eli lilly's once-daily weight loss pill foundayo, study examines potential link between glp-1 drugs and temporary hair loss, among other significant events and policy changes.

Source: Geo Health Space